International Scientific Advisory Committee (ISAC)

ISAC was established to co-ordinate and harmonise the activities of the Working Parties and to advise the Scientific Secretary about possible choices for the scientific program and speakers at ISBT congresses.

The International Scientific Advisory Committee (ISAC) meets once a year during a congress. The committee is chaired by the immediate Past President and includes all the chairpersons of the ISBT Working Parties together with the Secretary General and the Scientific Secretary.

 Terms of Reference

 

Members of the International Scientific Advisory Committee

Erica Wood

Erica Wood

ISBT Past President, Professor, Transfusion Medicine Specialist, Transfusion Research Unit, Monash University School of Public Health and Preventive Medicine, Melbourne, Victoria, Australia

Gwen Clarke

Gwen Clarke

ISBT Secretary General, Chair of the Vox SC; Associate Medical Director,, Canadian Blood Services, Edmonton, Canada

Jason Acker

Jason Acker

ISBT Scientific Secretary 2022 - 2025, Senior Scientist, Canadian Blood Services, Edmonton, Canada

Justina Kordai Ansah

Justina Kordai Ansah

Blood Supply Management Working Party Chair, Director, National Blood Service Ghana

Mickey Koh

Mickey Koh

Cellular Therapies Working Party Chair, Director, Stem Cell Transplantation at St George's hospital and Medical School, London, UK

Arwa Al Riyami

Arwa Al Riyami

Clinical Transfusion Working Party Chair, Senior Consultant Hematopathologist, Sultan Qaboos University Hospital, Muscat, Oman

Karin Magnussen

Karin Magnussen

Donors and Donation Working Party Chair, Medical Director, Dept. Blood Centre and Laboratory Medicine, Innlandet Hospital, Norway

Behnaz Bayat

Behnaz Bayat

Granulocyte Immunobiology Working Party Chair, Specialist, Clinical Immunology and Transfusion Medicine, Justus-Liebig University, Giessen, Germany

Mary Townsend

Mary Townsend

Haemovigilance Working Party Chair, Senior Medical Director, Vitalant, Phoenix, Arizona, US

Thierry Peyrard

Thierry Peyrard

Immunohaematology Working Party Chair, Rare Donors Vice Chair, Director, National Reference Department of Immunohematology and Rare Blood, French Blood Establishment (EFS), Paris, France

Jay Epstein

Jay Epstein

Global Blood Supply Working Party Chair, Medical Officer, COVID-19 Therapeutics Program, Office of the Assistant Secretary for Preparedness and Response, HHS, US

Suzanne Butch

Suzanne Butch

Information Technology Working Party Chair, Consultant, University of Michigan, United States

Brian Curtis

Brian Curtis

Platelet Immunobiology Working Party Chair, Director, Versiti Blood Research Institute, Milwaukee, Wisconsin, US

Christian Seidl

Christian Seidl

Quality Management Working Party Chair, Vice Medical Director, German Red Cross BDS, Frankfurt, Germany

Vered Yahalom

Vered Yahalom

Rare Donors Working Party Chair, Head of Department of Transfusion Medicine and Apheresis, Hadassah School of Medicine, Hebrew University, Jerusalem, Israel

Christoph Gassner

Christoph Gassner

RCIBGT Working Party Co-Chair, Professor, Private University in the Principality of Liechtenstein

Catherine Hyland

Catherine Hyland

RCIBGT Working Party Co-Chair, Principal Research Fellow, Australian Red Cross LifeBlood, Queensland, Australia

Brian Custer

Brian Custer

TTID Working Party Chair, Director , Epidemiology and Policy Science VP of Research and Scientific Programs, Vitalant, San Francisco, US